When will it be possible to spend $10 million or less to edit your genes to require less sleep?
InflationOne-OffRegulaciónHealth & MedicineCrime & JusticeManifold MarketsSin KYCDatos de resolución verificadosCalibración aceptablePronóstico comunitario actual2048-2054 15%Líder entre 10 opciones
Pronosticadores
4
Tipo de pregunta
multiple choice
Metodología
Play-money forecasting platform
Tipo de fuente
Pronóstico
Cambio 7d
0.0 pts
Datos de mercado
Actualizado hace 23 horas
Desactualizado12 ago 26, 0:16 UTC1 ene 00, 4:59 UTC
Tendencias
Mercados Relacionados
Preguntas relacionadas para dar contexto, no una comparación de contratos equivalentes.
Do short sleeper genes exist, and do they accelerate repair proccesses?
Manifold MarketsWill hemp-derived CBN sleep products still be federally legal as “hemp” on Nov 12, 2026?
Manifold MarketsHow many hours of sleep will I average per day in September? [WITH UPDATES]
Manifold MarketsWill SCOTUS require 12-person juries for serious felonies?
KalshiWill Virginia require data centers to use clean energy?
KalshiClavicular sentenced to prison?
PolymarketReglas
Resolution criteria
- This market will resolve to the date on which a gene-editing therapy designed to safely and permanently reduce human sleep requirements becomes commercially or clinically available to consumers for a total cost of $10 million USD or less (including the therapeutic agents and the required medical procedure).
- To satisfy the resolution criteria, the therapy must meet the following conditions:
- Target Mechanism: The therapy must target genetic pathways scientifically associated with sleep duration or sleep efficiency (such as DEC2, ADRB1, NPSR1, GRM1, or equivalent sleep-regulating genes).
- Availability: The treatment must be legally accessible to paying patients, either via approval from a major regulatory body (e.g., the US FDA or EMA) or through a verified, legally operating commercial clinic (including medical tourism).
- Cost: The total retail or out-of-pocket price for a single patient must be publicly documented as $10 million USD or less (adjusted for inflation from 2026).